Vasopressin receptor antagonists: will the "vaptan...[JAMA. 2004]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

1: JAMA. 2004 Apr 28;291(16):2017-8. Links

Vasopressin receptor antagonists: will the "vaptans" fulfill their promise?

PMID: 15113822 [PubMed - indexed for MEDLINE]

ReviewVasopressin antagonism: a future treatment option in heart failure.
Eur Heart J. 2005 Mar; 26(6):538-43. Epub 2005 Feb 4.

[Eur Heart J. 2005]
ReviewVasopressin-receptor antagonists in heart failure.
Am J Health Syst Pharm. 2008 May 1; 65(9):807-17.

[Am J Health Syst Pharm. 2008]
ReviewVasopressin antagonists in heart failure.
Curr Heart Fail Rep. 2004 Dec; 1(4):190-6.

[Curr Heart Fail Rep. 2004]
Climbing the mountain of acute decompensated heart failure: the EVEREST Trials.
JAMA. 2007 Mar 28; 297(12):1374-6. Epub 2007 Mar 25.

[JAMA. 2007]
Conivaptan: potential therapeutic implications in heart failure.
Recent Pat Cardiovasc Drug Discov. 2008 Jun; 3(2):137-40.

[Recent Pat Cardiovasc Drug Discov. 2008]
» See reviews... | » See all...

Your browsing activity is empty.

Activity recording is turned off.

Display Show